Anastrozole/Levonorgestrel

阿那曲唑/左炔诺孕酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnastrozole/Levonorgestrel
Drug Alias Name左炔诺孕酮/阿那曲唑Levonorgestrel and AnastrozoleLevonorgestrel/AnastrozoleAnastrozole and LevonorgestrelBAY-98-7196 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAromatase inhibitorsProgesterone receptor agonists
TargetsAromataseProgesterone receptor
Therapy Area/IndicationsContraception
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AnastrozoleLevonorgestrel
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsContraception

Other Information

ATC CodeN/A
Related LinksN/A